Profilo
Mr. Frédéric Dumais is a Director-Communications & Investor Relations at ChitogenX, Inc., a Director-Communications & Investor Relations at Valeo Pharma, Inc. and a Member at Québec Bar Assoication.
Mr. Dumais was previously employed as a Senior Director-Communications & IR by Liminal BioSciences, Inc., a Vice President-Investor Relations by Akela Pharma, Inc., a Head-Investor Relations by Janssen Pharmaceutica NV, and a Vice President-Investor Relations by LAB International, Inc.
Posizioni attive di Frédéric Dumais
| Società | Posizione | Inizio |
|---|---|---|
| VALEO PHARMA INC. | Contatto Relazioni con gli Investitori | 01/06/2019 |
| CHITOGENX INC. | Contatto Relazioni con gli Investitori | 01/06/2019 |
Québec Bar Assoication
Québec Bar Assoication Financial ConglomeratesFinance Provides fund management services | Corporate Officer/Principal | - |
Precedenti posizioni note di Frédéric Dumais
| Società | Posizione | Fine |
|---|---|---|
LAB International, Inc.
LAB International, Inc. Pharmaceuticals: MajorHealth Technology Develops, researches and discovers generic therapeutics | Public Communications Contact | 13/07/2007 |
| LIMINAL BIOSCIENCES INC. | Contatto Relazioni con gli Investitori | - |
Janssen Pharmaceutica NV
Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Engages in research, development and production of drugs | Contatto Relazioni con gli Investitori | - |
Akela Pharma, Inc.
Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical formulations and drugs | Public Communications Contact | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Liminal BioSciences, Inc.
Liminal BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops distinctive novel small molecule therapeutics for metabolic, fibrotic and inflammatory diseases | Health Technology |
LAB International, Inc.
LAB International, Inc. Pharmaceuticals: MajorHealth Technology Develops, researches and discovers generic therapeutics | Health Technology |
Akela Pharma, Inc.
Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical formulations and drugs | Health Technology |
Québec Bar Assoication
Québec Bar Assoication Financial ConglomeratesFinance Provides fund management services | Finance |
Janssen Pharmaceutica NV
Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Engages in research, development and production of drugs | Health Technology |
ChitogenX, Inc.
ChitogenX, Inc. BiotechnologyHealth Technology Operates as a development stage biotechnology company | Health Technology |
Valeo Pharma, Inc.
Valeo Pharma, Inc. Medical DistributorsDistribution Services Wholesales and retails pharmaceuticals & hospital specialty products | Distribution Services |
















